NCT04975958 2025-06-22Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid TumorsAdlai Nortye Biopharma Co., Ltd.Phase 1 Completed47 enrolled
NCT06349408 2025-01-27IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsInnovent Biologics (Suzhou) Co. Ltd.Phase 1 Recruiting250 enrolled